首页 > 市场调查报告书 > 製药

骨疾病

市场调查报告书

商品编码

1461288

服务疾病治疗市场，依疾病类型、按药物、按应用、按给药途径、按配销通路、按地理位置

Severs Disease Treatment Market, By Disease Type, By Drug, By Application, By Route of Administration, By Distribution Channel, By Geography

出版日期: 2024年03月08日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2024 年全球严重疾病治疗市场价值为 13.4 亿美元，预计到 2031 年将达到 18.7 亿美元，2024 年至 2031 年年复合成长率(CAGR) 为 4.9%。

报告范围		报告详情
基准年：	2023年	2023/2024 年市场规模：	13.4 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测期间 2023/2024 至 2030/2031 年复合成长率：	4.90%	2030/2031 价值预测：	18.7 亿美元

各种疾病治疗市占率 (%)，按地区，2024 年

塞弗氏症，也称为跟骨骨突炎，是活跃儿童足跟疼痛的常见原因。这是由于孩子进行跑步和跳跃等高衝击力活动时，跟骨（跟骨）的生长板受到压力和损伤而引起的。由于生长板尚未完全形成，这会反覆拉动生长板，从而导致发炎和疼痛。它通常影响 8 至 14 岁的儿童，因为他们的脚跟骨正在快速生长。跟骨过度生长暂时超过了生长板韧带的强度，从而引起症状。治疗的目的是在生长板完全形成时减少活动并缓解症状。

市场动态：

全球塞弗氏症治疗市场的推动因素是儿童参与体育活动的增加以及家长对足部和脚踝疾病的认识不断提高。此外，不断发展的医疗基础设施和越来越多的医疗诊断和治疗选择也推动了市场的成长。但塞弗氏症常被误诊为跟腱炎或足底筋膜炎，一定程度上抑制了市场。此外，物理治疗等替代疼痛管理疗法也构成了挑战。关键机会包括制定先进的治疗方案、利用远距医疗以及针对渗透率不足的地区。

研究的主要特点：

该报告深入分析了全球塞弗氏症治疗市场，并提供了预测期（2024-2031）的市场规模（十亿美元）和年复合成长率（CAGR%），以2023年为基准年。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数（例如公司亮点、产品组合、主要亮点、财务表现和策略）介绍了全球塞弗氏症治疗市场的主要参与者。
本研究涵盖的主要公司包括阿斯特捷利康、Horizon Therapeutics plc、赛诺菲、诺华公司、Sun Pharmaceutical Industries Ltd.、Cipla Inc.、LEO Pharma A/S、AbbVie Inc.、Mylan NV、Teva Pharmaceutical Industries Ltd.。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球塞弗疾病治疗市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和金融分析师。
利害关係人可以透过用于分析全球塞弗氏症治疗市场的各种策略矩阵轻鬆做出决策。

AstraZeneca
- 公司简介
- 产品/服务组合
- 财务绩效
- 最新动态/更新
- 战略概览
Horizon Therapeutics plc
Sanofi
Novartis AG
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
LEO Pharma A/S
AbbVie Inc.
Mylan NV
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lonza
Lupin
Dr. Reddy's Laboratories Ltd.
IBSA Institut Biochimique SA

第 11 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6737

The global Sever's Disease Treatment Market is estimated to be valued at USD 1.34 Bn in 2024 and is expected to reach USD 1.87 Bn by 2031, growing at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 1.34 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	4.90%	2030/2031 Value Projection:	US$ 1.87 Bn

Severs Disease Treatment Market Share (%), By Region, 2024

Sever's disease, also known as calcaneal apophysitis, is a common cause of heel pain in active children. It is caused by the growth plate of the heel bone (calcaneus) being stressed and injured as the child engages in high-impact activities like running and jumping. As the growth plate is not yet fully formed, this repetitively pulls on the growth plate which leads to inflammation and pain. It typically affects children between ages 8-14, as their heel bones are growing rapidly. The excessive heel bone growth temporarily outstrips the strength of the growth plate ligaments causing symptoms. Treatment aims to reduce activity and relieve symptoms while the growth plate fully forms.

Market Dynamics:

The global Sever's disease treatment market is driven by the rising participation of children in sports activities and growing awareness among parents regarding foot and ankle conditions. Moreover, the developing healthcare infrastructure and increasing access to medical diagnosis and treatment options is also fueling the market growth. However, frequent misdiagnosis of Sever's disease as Achilles tendinitis or plantar fasciitis restraints the market to some extent. Furthermore, alternative pain management therapies like physiotherapy pose a challenge. Key opportunities include development of advanced treatment protocols, leveraging telemedicine, and targeting underpenetrated regions.

Key Features of the Study:

This report provides an in-depth analysis of the global Sever's disease treatment market, and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global Sever's disease treatment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include AstraZeneca, Horizon Therapeutics plc, Sanofi, Novartis AG, Sun Pharmaceutical Industries Ltd., Cipla Inc., LEO Pharma A/S, AbbVie Inc., Mylan N.V., Teva Pharmaceutical Industries Ltd., Aurobindo Pharma, Lonza, Lupin, Dr. Reddy's Laboratories Ltd., and IBSA Institut Biochimique SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global Sever's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Sever's disease treatment market.

Detailed Segmentation:

Disease Type:
- Acute
- Chronic
Drug:
- Diclofenac
- Etodolac
- Indomethacin
- Celecoxib
- Others
Type:
- Over-the-counter
- Prescription
Route of Administration:
- Oral
- Parenteral
- Others (Topical, etc.)
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- AstraZeneca
- Horizon Therapeutics plc
- Sanofi
- Novartis AG
- Sun Pharmaceutical Industries Ltd.
- Cipla Inc.
- LEO Pharma A/S
- AbbVie Inc.
- Mylan N.V.
- Teva Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lonza
- Lupin
- Reddy's Laboratories Ltd.
- IBSA Institut Biochimique SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Drug
- Market Snapshot, By Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Scenario - Conservative, Likely, Opportunistic
Market Opportunity Map

3. Key Insights

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Pest Analysis
Porters Analysis
Technological Advancements
Merger, Acquisition and Collaboration Scenario
Recent Product Approvals
Company Market Share Analysis
Identification of Key Players in each Region
Regulatory Scenario
Pricing Analysis

4. Global Sever's Disease Treatment Market, By Disease Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Acute, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Chronic, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

5. Global Sever's Disease Treatment Market, By Drug, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Diclofenac, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Etodolac, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Indomethacin, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Celecoxib, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others (Naproxen, etc.) , 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

6. Global Sever's Disease Treatment Market, By Type, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Over-the-counter, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Prescription, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

7. Global Sever's Disease Treatment Market, By Route of Administration, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Oral, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Parenteral, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Others (Topical, etc.), 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

8. Global Sever's Disease Treatment Market, By Distribution Channel, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031
- Market Y-o-Y Growth Comparison (%), 2020 - 2031
- Segment Trends
Hospital Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Retail Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)
Online Pharmacies, 2019 - 2031(US$ Billion)
- Introduction
- Market Size and Forecast, 2019 - 2031, (US$ Billion)

9. Global Sever's Disease Treatment Market, By Region, 2019 - 2031 (US$ Billion)

Introduction
- Market Share (%) Analysis, 2024, 2027 & 2031, (US$ Billion)
- Market Y-o-Y Growth Comparison (%), 2020 - 2031, (US$ Billion)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest Of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
China
India
Japan
Australia
South Korea
ASEAN
Rest Of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Middle East
Middle East
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country, 2019 - 2031, (US$ Billion)
GCC
Israel
Rest of the Middle East
Africa
- Introduction
- Market Size and Forecast, By Disease Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Drug, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Type, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Route of Administration, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Distribution Channel, 2019 - 2031, (US$ Billion)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (US$ Billion)
South Africa
North Africa
Central Africa

10. Company Profiles - Global Sever's Disease Treatment Market

AstraZeneca
- Company Overview
- Product/Service Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategic Overview
Horizon Therapeutics plc
Sanofi
Novartis AG
Sun Pharmaceutical Industries Ltd.
Cipla Inc.
LEO Pharma A/S
AbbVie Inc.
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Aurobindo Pharma
Lonza
Lupin
Dr. Reddy's Laboratories Ltd.
IBSA Institut Biochimique SA